Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.76M$1.76Mderived+71.6% vs Q4 2022 Net Income-$5.41M-$5.41MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$505,000+155.1% Operating Incomederived-$5,808,000N/M Operating Cash Flowderived-$4,177,000N/M Free Cash Flowderived-$4,392,000N/M Margins · derivedGross margin28.7%+9.4 pt vs Q4 2022
Operating margin-329.8%+151.3 pt vs Q4 2022
Net margin-306.9%+165.3 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 5, 2024 · 65 d after period end